FEDERAL LITIGATION. CLEARLY EXPLAINED.Attorney advertising Presented by JAG Legal Group
Back to MDL directory
Prescription drugs / MDL 3140

Depo-Provera

Claims involving injectable contraceptives and alleged intracranial meningiomas.

Settlement administrationBrief reviewed October 27, 2026
6,412pending federal actionsJPML · October 1, 2026
THE CASE AT A GLANCE

Case information

Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation

MDL number
3140
Transferee district
FLN
Presiding judge
M. Casey Rodgers
Master docket
3:25-md-3140
Transferred
02/07/2025
Total actions (historical)
6,524

Counts cover federal actions recorded in this MDL, not all people with similar injuries or cases in state court. JPML source ↗

Current status & progress

The court lists settlement-administration appointments dated September 4, 2026. Case Management Order 14 governs litigation continuing outside the settlement program. The court’s orders page lists a December 18, 2026 case management conference at 9:00 a.m. Central.

Selected court-source coverage

This brief summarizes the linked sources. It is not a complete docket review. Pending status alone does not establish that a claim is timely or that a firm is accepting it.

Settlement information

A private settlement program covers qualifying claims, rather than every person who used the medication. CMO 14 identifies November 30, 2026 as the registration deadline. Eligibility is governed by the settlement agreement and must be confirmed with counsel or the administrator. No individual payment amount is promised.

Settlement eligibility can depend on product, injury, filing date, defendant, and program-specific rules. This site does not calculate payouts.

Important dates

Nov 30, 2026

Settlement registration deadline

Eligible settlement-program claimants only; confirm eligibility and any changes with counsel.

Verify with the source
Dec 18, 2026

Case management conference

9:00 a.m. Central. Court calendar; subject to change.

Verify with the source

Dates may change. Contact your attorney or the court/administrator to confirm. An inquiry through this site does not preserve a deadline.

Information for a case review

JAG Legal Group can review your circumstances to determine whether representation may be available. The following is an evidence checklist, not a promise of eligibility.

  • Product name, manufacturer, and approximate injection dates
  • Date and medical confirmation of an intracranial meningioma diagnosis
  • State of use and residence, and any existing attorney or filed claim
  • Whether you are already registered for the settlement program

Please keep medical records and sensitive documents for a direct discussion with the legal team. The initial contact form does not request document uploads.

Request a review for MDL 3140

Sources & record coverage

Primary sources checked October 27, 2026. Current public pages can lag the official PACER docket. Read our methodology.